01 3Rezaltas
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 123
2019 Revenue in Millions : 137
Growth (%) : -11
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 104
2020 Revenue in Millions : 122
Growth (%) : -8
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 139
2018 Revenue in Millions : 148
Growth (%) : -6
LOOKING FOR A SUPPLIER?
